Envision Pharma Group
9.5.2023 13:02:01 CEST | ACCESS Newswire | Press release
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2023 / Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors.
"We are pleased to welcome Deepti to the Envision Board of Directors," shares Meg Heim, CEO of Envision Pharma Group. "Deepti's deep experience in the technology of Artificial Intelligence (AI) and digital therapeutics in the life sciences industry will be invaluable to our mission at Envision as we continue to accelerate our global business expansion and commitment to our clients, and most importantly, impacting patient lives in a positive manner."
Dr. Jaggi's career includes over 20 years of experience in driving innovation at the intersection of life sciences, healthcare, and technology. Her expertise is in transforming businesses through software, AI/ML, and advanced analytics. Most recently, she served as Chief Strategy & Commercial Officer at Better Therapeutics, a publicly held digital therapeutics company. Before that, she served as the Global Head of Patient Insights & Solutions at Astellas Pharmaceuticals with responsibility for the Americas, EMEA, China, and Japan.
Prior to that, Dr. Jaggi served as President & Chief Medical Officer at Clinakos Inc., a Silicon Valley company at the forefront of leveraging data and AI in healthcare and life sciences. She helped grow Clinakos from startup to revenue stage, serving multiple top pharmaceutical companies.
Dr. Jaggi's previous experience includes positions of increasing responsibility and leadership at Johnson & Johnson, Genentech, Oracle, and Kaiser Permanente. She has also served as a consultant to TPG Capital and is a member of the Board of Directors for Technology Credit Union in the San Francisco Bay Area.
"I am thrilled to join the Envision Board at such an exciting time for our industry. I look forward to working with an immensely talented team to accelerate innovation in life sciences through technology and scientific solutions to positively impact patient lives," says Dr. Jaggi.
Dr. Jaggi's educational background includes a PharmD from the University of Southern California and an MBA from Stanford Graduate School of Business.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.
Contact Information
Colleen Carter
Associate Director, Communications, Office of the CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856
SOURCE: Envision Pharma Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/753175/Envision-Pharma-Group-Announces-Appointment-of-Dr-Deepti-Sodhi-Jaggi-to-Board-of-Directors
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Schedules Conference Call to Discuss First Quarter 2026 Financial Results on Friday, May 15, 202630.4.2026 21:00:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / April 30, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset ("RWA") tokenization technologies, today announced that it will report financial results for its first quarter of 2026 prior to market open on Friday, May 15, 2026. Following the release, Datavault AI will host a conference call and live webcast on the same day, at 8:30 a.m. ET. Conference Call and Webcast Information Date: Friday, May 15, 2026, at 8:30 a.m. ET Participant Dial-in (US): 1-877-709-8150 Participant Dial-in (International): 1-201-689-8354 -- or Click HERE for participant International Toll-Free access numbers Webcast Access: Click Here Datavault AI CEO, Nathaniel Bradley, and CFO Brett Moyer, will be presenting. A replay of the webcast will be made available later in the day in the Investors/Presentations section of the Datavault AI website: Click Here About Datavau
POLARIS Laboratories Expands Globally with Acquisition of UK-Based Oil Check Laboratory Services30.4.2026 20:42:00 CEST | Press release
POLARIS Laboratories® acquires Oil Check Laboratory Services LTD (OCLS), a strategic step in supporting growing industries, markets and key global customers. INDIANAPOLIS, IN / ACCESS Newswire / April 30, 2026 / POLARIS Laboratories® announces the acquisition of Oil Check Laboratory Services Ltd (OCLS), a well-established fluid analysis laboratory headquartered in Doncaster, United Kingdom. The transaction represents a strategic step in POLARIS Laboratories' expansion into supporting new markets including data centers, power generation and transformer oils, enhancing its international presence and strengthening its ability to serve customers across key global markets. OCLS is recognized for its high-quality lubricant and diesel fuel testing, as well as condition monitoring services, supporting a diverse base of industrial and mobile equipment applications. The combination of companies brings together complementary technical capabilities, increased testing capacity, and an expanded regi
OMP Ranked in Highest Two Across All Four Use Cases in the 2026 Gartner(R) Critical Capabilities for Supply Chain Planning Solutions: Process Industries30.4.2026 15:00:00 CEST | Press release
ANTWERPEN, BE / ACCESS Newswire / April 30, 2026 / OMP, a leading provider of AI-powered supply chain planning, has been ranked in highest two across all four Use Cases in the 2026 Gartner® Critical Capabilities for Supply Chain Planning Solutions report for process industries. This report, a companion to the Gartner® Magic Quadrant™, evaluates 16 vendors on Critical Capabilities and real-world Use Cases, helping organizations assess how well solutions support different levels of supply chain planning maturity. This recognition follows OMP's recent position as highest in Ability to Execute and furthest in Completeness of Vision in the 2026 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions: Process Industries. Get the full Gartner® Critical Capabilities report. Consistent strength in real-world planning Use Cases The critical capabilities that most distinguish supply chain planning (SCP) vendors for process industries from each other in 2026 are AI-driven planning and decisio
Karbon-X Advances Sur del Meta REDD+ Project with Biodiversity Partnership30.4.2026 15:00:00 CEST | Press release
Collaboration supports the use of ecological data in project design as demand for high-integrity carbon credits accelerates. CALGARY, AB / ACCESS Newswire / April 30, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions provider operating across compliance and voluntary carbon markets, today announced the formalization of a strategic partnership with Fundación BioHerencia, a participating landowner of the REDD+ project Sur del Meta currently being implemented in Colombia. The partnership aims to embed biodiversity conservation within the REDD+ project by combining the landowner's conservation expertise with community-based monitoring efforts. The agreement establishes a technical, scientific, and operational framework to support the integration of field-based ecological data into the project's Measurement, Reporting, and Verification (MRV) systems. As a participating landowner within the REDD+ project, BioHerencia owns Harpy Eagle
Datavault AI and Kings Mine Capital Agree to Establish $150 Million+ GoldVault(TM) Tokenization Program30.4.2026 15:00:00 CEST | Press release
Agreement Contemplates Bullion at $3,000 an Ounce to Spot for 24-Month Delivery with $40 Million Projected Profit at $5000 an Ounce. GoldVault™ Tokens Issue at Discount to Spot with Production-Linked Royalty Stream PHILADELPHIA, PA / ACCESS Newswire / April 30, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, and King Mining Capital ("King Mining Capital") today announced that they have entered into a agreement for a multi-component strategic transaction that will combine a Datavault AI equity investment in King Mining Capital, a Datavault AI stock-funded purchase of 20,000 ounces of physical gold bullion, and the launch of a $150 million-plus GoldVault™ tokenization program backed by King Mining Capital's high-grade gold resources. Direct Equity, Physical Bullion, and Stock-Funded Consideration Subject to entering into a definitive agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom